Results
71,097 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 10 | Rothblatt Martine ADirector, Chairperson & CEO |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $47K 80 sh |
Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 10 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $47K 80 sh |
| Nov 6, 2026 traded Nov 5, 2026 |
| 10 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $24K 40 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 10 | Wang YanjunCCO and GC |  SESea LtdOpen-market sale · 10b5-1 plan | SELL | $19K 236 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 10 | Wang YanjunCCO and GC | SESea Ltd Open-market sale · 10b5-1 plan | SELL | $41K 500 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 10 | Wang YanjunCCO and GC | SESea Ltd Open-market sale · 10b5-1 plan | SELL | $5,080 64 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 10 | O'Day Daniel PatrickDirector, Chairman & CEO |  GILDGILEAD SCIENCES, INC.Open-market sale · 10b5-1 plan | SELL | $1.72M 9,810 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 10 | DIRK VAN DE PUTDirector, Chief Executive Officer |  MDLZMondelez International, Inc.Open-market sale · 10b5-1 plan | SELL | $1.42M 20.9K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 9 | Kersey MelissaEVP Chief HR Officer |  TSCOTRACTOR SUPPLY CO /DE/Grant or award | A | — 2,853 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Eisenhardt Shannon SDirector |  UPSUNITED PARCEL SERVICE INCGrant or award | A | — 918 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Jackson JamereCFO |  AZOAUTOZONE INCOption exercise | M | — 6,900 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Anderson JudyVP/CFO |  WEYSWEYCO GROUP INCOption exercise | M | $14K 600 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 9 | Anderson JudyVP/CFO | WEYSWEYCO GROUP INC Option exercise | M | $14K 600 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 9 | Stillwell KennethCOO, CFO |  PEGAPEGASYSTEMS INCOption exercise | M | — 25.9K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Nieuwoudt Stacy DurbinDirector |  ASPNASPEN AEROGELS INCGrant or award | A | — 6,073 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Popovich TimothyChief Operating Officer |  CLMBClimb Global Solutions, Inc.Tax withholding | F | $11K 262 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 9 | Hastings ChuckDirector |  APLDApplied Digital Corp.Grant or award | A | — 14.4K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Bass Charles EdwardChief Alliance Officer | CLMBClimb Global Solutions, Inc. Tax withholding | F | $37K 854 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 9 | Sullivan Matthew MChief Financial Officer | CLMBClimb Global Solutions, Inc. Tax withholding | F | $14K 320 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 9 | Pratt Ryan MichaelDirector, Chief Executive Officer |  GUERGuerrilla RF, Inc.Acquisition by will | W | — 1,497 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Klemp Walter VDirector, CEO and President |  MBRXMoleculin Biotech, Inc.Option exercise | M | — 57 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Foster Jonathan P.Chief Financial Officer | MBRXMoleculin Biotech, Inc. Option exercise | M | — 41 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Foster Jonathan P.Chief Financial Officer | MBRXMoleculin Biotech, Inc. Tax withholding | F | $84.6 10 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Prime Joshua EDirector |  LEVILEVI STRAUSS & COGrant or award | A | — 111 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Foster Jonathan P.Chief Financial Officer | MBRXMoleculin Biotech, Inc. Option exercise | M | — 41 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Patrick ArtemisDirector | LEVILEVI STRAUSS & CO Grant or award | A | — 72 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Ming Jenny JDirector | LEVILEVI STRAUSS & CO Grant or award | A | — 109 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Ming Jenny JDirector | LEVILEVI STRAUSS & CO Grant or award | A | — 57 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Marberger David SDirector | LEVILEVI STRAUSS & CO Grant or award | A | — 77 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Jones Jeffrey J IIDirector | LEVILEVI STRAUSS & CO Grant or award | A | — 71 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Geballe Daniel WDirector | LEVILEVI STRAUSS & CO Grant or award | A | — 137 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Garten YaelDirector | LEVILEVI STRAUSS & CO Grant or award | A | — 163 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Beraud JillDirector | LEVILEVI STRAUSS & CO Grant or award | A | — 97 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Lanoy Jonathan DavidSVP, Chief Accounting Officer |  NATRNATURES SUNSHINE PRODUCTS INCOption exercise | M | — 1,114 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Lanoy Jonathan DavidSVP, Chief Accounting Officer | NATRNATURES SUNSHINE PRODUCTS INC Tax withholding | F | $860 67 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Beraud JillDirector | LEVILEVI STRAUSS & CO Grant or award | A | — 57 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Alstead TroyDirector | LEVILEVI STRAUSS & CO Grant or award | A | — 318 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Alstead TroyDirector | LEVILEVI STRAUSS & CO Grant or award | A | — 89 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 9 | Stillwell Mary-LeeSVP and Controller |  VZVERIZON COMMUNICATIONS INCGrant or award | A | $585 44 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 9 | O'Neill Gilmore NeilDirector, CEO |  EDITEditas Medicine, Inc.Grant or award | A | — 43.6K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 9 | Lanoy Jonathan DavidSVP, Chief Accounting Officer | NATRNATURES SUNSHINE PRODUCTS INC Option exercise | M | — 163 sh | Nov 6, 2026 traded Nov 4, 2026 |